BioTechniques is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Journal
    • Aims and scope
    • Journal archive
    • Editorial board
    • For authors
    • Your editors: what do we do?

    Follow us on social media

  • Current issue
  • News
    • Latest news
    • Tech news
    • Events news
    • Company news

    Follow us on social media

  • Multimedia
    • Downloadable eBooks
    • Infographics
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • Features
    • Interviews
    • Opinion
    • In Focus
    • Spotlights
    • Companies
    • New products
    • Events

    Follow us on social media

  • Topics
    • Analytical chemistry
      • Biochemistry
      • Bioengineering and biophysics
      • Cancer research
      • Careers and Publishing
      • Cell and tissue biology
      • COVID-19
      • CRISPR
      • Computational biology
    • Diagnostics and preclinical
      • Drug discovery and development
      • Immunology
      • Lab design and machinery
      • Microbiology
      • Molecular biology
    • Nanomedicine
      • Neuroscience
      • PCR and sequencing
      • Plant and climate science
      • Proteomics
      • Veterinary science
      • Whole-genome studies

    Follow us on social media

  • Become a member
Our new In Focus on organ-on-a-chip technology is live! CHECK IT OUT

PCR and sequencing

The polymerase chain reaction (PCR) and sequencing are intricately linked and vital to many fields in the life sciences. First invented in 1983, PCR is used to dramatically amplify DNA in a matter of hours. Aspects of the PCR and Sanger sequencing working principles are similar, both involving DNA polymerase and a

Read more...
specific set of primers for the reaction.

PCR amplification also plays a key role in next-generation sequencing (NGS) techniques, amplifying DNA samples before the PCR product is used for sequencing. Specific DNA sequences can also be selected for target enrichment by PCR-based processes, making NGS studies cheaper and decreasing the amount of genomic DNA needed in a sample for the generation of an accurate sequencing read. Since the inception of both DNA sequencing and PCR, the technologies have progressed rapidly, with new iterations, such as long-read nanopore sequencing and ddPCR improving the speed, accuracy, ease of use and flexibility of these techniques.

Read more about PCR and sequencing techniques in our peer reviewed journal.

  • About BioTechniques
  • Advisory Board
  • Contact Us
  • Advertising
  • Permissions
  • Whitelist Emails
Contact
Contact Us
Office info

BioTechniques is powered by Taylor & Francis Group

BioTechniques, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom

Impact Factor 2.2 | CiteScore 2.0

  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 BioTechniques